Mass spectrometric studies of the variety of beta‐amyloid proteoforms in Alzheimer's disease
Mass Spectrometry Reviews · 2025-01 · 44 (1) · 3-21
DOI: 10.1002/mas.21775 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mass Spectrometry Reviews, online erschienen am 28.03.2022. Verfasst von Natalia V Zakharova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, Moscow, Russia. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 140 Literaturangaben. Gefördert von: Ministry of Science and Higher Education of the Russian Federation, Ministry of Science and Higher Education of the Russian Federatio.
Themen: Demenz
Abstract (Originalsprache)
This review covers the results of the application of mass spectrometric (MS) techniques to study the diversity of beta‐amyloid (Aβ) peptides in human samples. Since Aβ is an important hallmark of Alzheimer's disease (AD), which is a socially significant neurodegenerative disorder of the elderly worldwide, analysis of its endogenous variations is of particular importance for elucidating the pathogenesis of AD, predicting increased risks of the disease onset, and developing effective therapy. MS approaches have no alternative for the study of complex samples, including a wide variety of Aβ proteoforms, differing in length and modifications. Approaches based on matrix‐assisted laser desorption/ionization time‐of‐flight and liquid chromatography with electrospray ionization tandem MS are most common in Aβ studies. However, Aβ forms with isomerized and/or racemized Asp and Ser residues require the use of special methods for separation and extra sensitive and selective methods for detection. Overall, this review summarizes current knowledge of Aβ species found in human brain, cerebrospinal fluid, and blood plasma; focuses on application of different MS approaches for Aβ studies; and considers the potential of MS techniques for further studies of Aβ‐peptides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, Moscow, Russia.
- CMCB, Skolkovo Institute of Science and Technology, Moscow, Russia.
- Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
- Laboratory of ion and molecular physics, Moscow Institute of Physics and Technology, Dolgoprudny, Russia.
- N.N. Semenov Federal Center of Chemical Physics, V.L. Talrose Institute for Energy Problems of Chemical Physics, Russian Academy of Sciences, Moscow, Russia.
Förderung
- Ministry of Science and Higher Education of the Russian Federation
- Ministry of Science and Higher Education of the Russian Federatio
Zitieren
APA
Zakharova, N. V., Kononikhin, A. S., Indeykina, M. I., Bugrova, A. E., Strelnikova, P., Pekov, S., Kozin, S. A., Popov, I. A., Mitkevich, V., Makarov, A. A., & Nikolaev, E. N. (2025). Mass spectrometric studies of the variety of beta‐amyloid proteoforms in Alzheimer's disease. Mass Spectrometry Reviews, 44(1), 3-21. https://doi.org/10.1002/mas.21775
Vancouver
Zakharova NV, Kononikhin AS, Indeykina MI, Bugrova AE, Strelnikova P, Pekov S, et al. Mass spectrometric studies of the variety of beta‐amyloid proteoforms in Alzheimer's disease. Mass Spectrometry Reviews. 2025;44(1):3-21. doi:10.1002/mas.21775
BibTeX
@article{Zakharova2025,
author = {Zakharova, Natalia V and Kononikhin, Alexey S and Indeykina, Maria I and Bugrova, Anna E and Strelnikova, Polina and Pekov, Stanislav and Kozin, Sergey A and Popov, Igor A and Mitkevich, Vladimir and Makarov, Alexander A and Nikolaev, Evgeny N},
title = {Mass spectrometric studies of the variety of beta‐amyloid proteoforms in Alzheimer's disease},
journal = {Mass Spectrometry Reviews},
year = {2025},
volume = {44},
number = {1},
pages = {3--21},
doi = {10.1002/mas.21775}
}
EUVIMED